Crispr Infuses First Human in Landmark Gene-Editing Study
Crispr Therapeutics and partner Vertex Pharmaceuticals said on Monday morning that the first patient in a trial using CTX001 received the one-time medicine. February 26, 2019 at 02:17PM
Bitcoin, Ether Fail to Capitalise on Weekend Momentum as Altcoins Do Better
Bitcoin prices have remained highly volatile as traders fear the way their profits on tokens may be taxed under provisions of President Biden's recently enacted infrastructure act. November 23, 2021 at 11:36AM
Comments
Post a Comment